Pricing

how much is retatrutide

Published May 2, 2026Updated May 3, 2026Medical safety, official-source, and research-reference review

There is no official FDA-approved retail price for retatrutide because it is not approved for public sale.

Direct answer

Public pages may show prices for products claiming to be retatrutide, but those prices are not official drug prices and should not be treated as safe-buying signals.

Research context

These references frame the evidence base behind this topic. They are not medical advice, approval, or instructions for using retatrutide outside a clinical trial.

Short source quoteagonist of the GIP, GLP-1, and glucagon receptors

Jastreboff et al., NEJM 2023 retatrutide phase 2 obesity trial

This peer-reviewed phase 2 paper is the anchor for retatrutide mechanism language. It does not make retatrutide approved or publicly available.

Short source quoterandomised, double-blind, placebo and active-controlled

Rosenstock et al., Lancet 2023 retatrutide phase 2 type 2 diabetes trial

The type 2 diabetes phase 2 paper helps separate controlled clinical research from online self-use claims.

Short source quotequality of the prescription drugs sold online

Lim et al., 2022 systematic review of online pharmacies selling prescription drugs

This systematic review supports online-source caution for prescription-drug searches and marketplace claims.

Short source quoteselling counterfeit, adulterated or unapproved drugs

Limbu and Huhmann, 2023 scoping review of illicit online pharmacies

This scoping review supports warnings about illicit online pharmacies and unapproved prescription-drug access.

Short source quotepreparation errors

McCall et al., Expert Opinion on Drug Safety 2026 compounded GLP-1 pharmacovigilance study

This pharmacovigilance study is relevant to compounded GLP-1 safety signals and product-quality concerns.

What to know before acting on this search

Price claims can exclude shipping, import, checkout, tax, currency conversion, and stock limitations.
Low price does not prove identity, purity, storage, sterility, or legality.
This site treats prices as public listing claims for monitoring and comparison only.

Safety and compliance notes

A price can make an unapproved product look more legitimate than it is.
FDA says retatrutide is not a component of an FDA-approved drug and cannot be used in compounding.
Approved alternatives have labels, prescribers, pharmacies, and regulated supply chains.

Safer next step

Use the price comparison page for listing-claim context and the FDA status page for the official availability answer.

Medical disclaimer

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. I am not a medical professional. Always consult a qualified healthcare provider before starting, stopping, or changing any weight loss treatment. Individual results vary. Retatrutide is investigational and is not FDA approved. FDA-approved options such as semaglutide and tirzepatide require prescriptions and should only be used under medical supervision.